Abstracts tagged "systemic lupus erythematosus (SLE) and ultrasonography"

Abstract Number: 1838 • 2015 ACR/ARHP Annual Meeting
Joint Ultrasonography May be Useful to Assess Disease Activity in Systemic Lupus Erythematosus (SLE) Patients: A Prospective Multicenter Study
Carine Salliot¹, Emmanuelle Dernis Labous², Aleth Perdriger³, Jean David Albert⁴, Amelie Denis⁵, Saloua Mammou⁶, Isabelle Griffoul⁷, Benoit Le Goff⁸, Sandrine Jousse-Joulin⁹, Christophe Richez¹⁰, Nicolas Poursac¹⁰, Mohamed Hamidou¹¹, Virginie Martaille¹², Antoine Valery¹³ and Emilie Ducourau¹⁴, ¹Rheumatology, CHR Orleans, Orléans, France, ²Réseau Hôpital et Ville en Rhumatologie (RHEVER) Network, Paris, France, ³Service de Rhumatologie, CHU de Rennes, Rennes, France, ⁴Rheumatology Unit, Rennes, France, ⁵Rheumatology, CH Le Mans, Le Mans, France, ⁶Rheumatology, CHU Tours, Tours, France, ⁷Rheumatology, CHU TOURS, Tours, France, ⁸Rheumatology, Nantes University Hospital, Nantes, France, ⁹Rheumatology, CHu La cavle Blanche, Brest, France, ¹⁰Rheumatology, CHU Bordeaux, Bordeaux, France, ¹¹Internal Medicine Department, Nantes University Hospital, Nantes, France, ¹²Rheumatology, CHR Orléans, Orleans, France, ¹³Statistics, CHR Orleans, Orleans, France, ¹⁴Rheumatology, CHR Orleans, Orleans, France
Background/Purpose: Arthritis is a current manifestation of SLE and participates to the SLEDAI composite score calculation (0 to 105). Ultrasonography (US) is a validated and…
Abstract Number: 1586 • 2013 ACR/ARHP Annual Meeting
Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective
Elisabeth M.A Ball¹, Arthur Grey², Ai Lyn Tan³, Eiji Fukuba⁴, Gunter Steiner⁵, Dennis McGonagle⁶, Aubrey Bell⁷ and Madeleine Rooney⁸, ¹Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, ²Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, ³Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ⁴Department of Radiology, Shimane University, Izuma, Japan, ⁵Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ⁶NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, ⁷Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, ⁸Medicine, Queens University Belfast, Belfast, United Kingdom
Background/Purpose: Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].